Anemia Drug May Harm Some Patients, FDA Says
189562
The Food and Drug Administration warned yesterday that anemia-fighting drugs called erythropoietins, which had $10 billion in U.S. sales last year, are being used so aggressively that they may be harming some patients.
33587
Amgen Inc. and Johnson & Johnson anemia drugs will carry strong new warnings after studies showed a higher risk of death and life-threatening side effects in some patients, U.S. health officials said on Friday.
252006
NEW YORK  - Asian patients who are treated with anti-clotting drugs, also called "anti-thrombotics," after having a heart attack are more likely than their white counterparts to experience bleeding complications, new research suggests.
766886
A senior Medicare official said the case for cutting the use of controversial anemia drugs sold by Amgen Inc and Johnson &amp; Johnson has become stronger since the agency decided last year to cut payments for their use in cancer patients.
52899
A National Kidney Foundation panel will assess whether hundreds of thousands of patients with kidney disease are being dangerously overtreated with anemia drugs.
270075
A new study showing an increased risk of blood clots among women using a contraceptive skin patch prompted the Food and Drug Administration on Friday to add that finding to the drug's label.
552950
A newer drug appeared to delay the progression of the most common form of diabetes a little longer than two older medications but also raised the risk of heart problems, weight gain and fractures, a large study has found.
133219
NEW YORK  - In the US, at least one in five  people age 85 or older are anemic, according to a new report.  Although the anemia is rarely severe, further studies are  needed to determine the impact on quality of life and  functional abilities.
152135
Debate about the safety of a group of anemia drugs widely used in cancer patients should focus on a minority of patients who got the drugs for unapproved uses, doctors said on Sunday.
633305
Patients treated with widely used osteoporosis drugs may develop severe and sometimes disabling muscle, joint and bone pain, U.S. officials said on Monday in an alert highlighting the previously known risk.
726765
Amgen Inc. has added a warning to  its anemia drug, Aranesp, for kidney dialysis and cancer  patients after studies on similar drugs showed higher doses can  cause blood clots and death, the company said a letter released  on Friday.
429156
Doctors should stop using the anemia  drug Procrit, made by Johnson & Johnson's Ortho Biotech  Products L.P., if an oxygen-carrying agent in a patient's blood  reaches a certain level, the company said in documents released  on Wednesday.
193616
A âpoisonous cocktailâ of many drugs can interact in dangerous ways and cause side effects that can be far worse than the diseases they are treating.
653673
A new drug that can treat patients with multiple sclerosis has been approved by the Food and Drug Administration but the high cost of the medication has some people concerned.
572963
Older patients whose red blood cell counts are even slightly out of the normal range are at higher risk of death and heart problems after major surgery, U.S. researchers said on Tuesday.
243063
In Christopher Rowland's recent article, a Medicare official characterizes FDA drug labeling policy as setting ``minimum guidelines in terms of what people should be achieving" for red blood cell counts ( ``As kidney drug doses rise, so do warnings," Sept. 14 ).
31195
Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk of death and other serious problems in patients with cancer and kidney disease.